HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its severity in Brazilian patients

Tissue Antigens

Volumn 84, Issue 3, 2014, Pages 308-315

  Catamo, E ^a   Addobbati, C ^b   Segat, L ^c   Sotero Fragoso, T ^b   Domingues Barbosa, A ^b   Tavares Dantas, A ^b   de Ataide Mariz H ^b   da Rocha, L F ^b   Branco Pinto Duarte, A L ^b   Monasta, L ^c   Sandrin Garcia, P ^b   Crovella, S ^a,c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Brazilian patients; Genetic polymorphisms; Human leukocyte antigen G; mRNA instability; Rheumatoid arthritis

Indexed keywords

HLA G ANTIGEN; RHEUMATOID FACTOR; 3' UNTRANSLATED REGION;

ADULT; ARTICLE; BINDING AFFINITY; BRAZIL; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DNA POLYMORPHISM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; WILD TYPE; 3' UNTRANSLATED REGION; AGED; DISEASE COURSE; DNA FLANKING REGION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; 5' FLANKING REGION; AGED; ARTHRITIS, RHEUMATOID; BRAZIL; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84907338210     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12396     Document Type: Article

References (42)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Review Nature 2003: 423: 356-61.
2. MacGregor AJ, Snieder H, Rigby AS et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000: 43: 30-7.
3. Silva GL, Junta CM, Sakamoto-Hojo ET, Donadi EA, Louzada-Junior P, Passos GAS. Genetic susceptibility loci in rheumatoid arthritis establish transcriptional regulatory networks with other genes. Ann N Y Acad Sci 2009: 1173: 521-37.
4. Geraghty DE, Pei J, Lipsky B et al. Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes. Proc Natl Acad Sci U S A 1992: 189: 2669-73.
5. Carosella ED, HoWangYin KY, Favier B, LeMaoult J. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Review. Hum Immunol 2008: 69: 700-7.
6. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibits NK and antigen-specific CTL cytolisis. J Immunol 2001: 166: 5018-26.
7. Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999: 43: 203-11.
8. Fons P, Chabot S, Cartwright JE et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006: 108: 2608-15.
9. LeMaoult J, Caumartin J, Daouya M et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007: 109: 2040-8.
10. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Review. Mol Biol Evol 2011: 28: 3069-86.
11. Hviid TV, Milman N, Hylenius S, Jakobsen K, Jensen MS, Larsen LG. HLA-G polymorphisms and HLA-G expression in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006: 23: 30-7.
12. Park KS, Park JS, Nam JH, Bang D, Sohn S, Lee ES. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Tissue Antigens 2007: 69: 139-44.
13. Veit TD, Vianna P, Scheibel I et al. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens 2008: 71: 440-6.
14. Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006: 67: 561-7.
15. Kim SK, Chung JH, Kim DH, Yun DH, Hong SJ, Lee KH. Lack of association between promoter polymorphisms of HLA-G gene and rheumatoid arthritis in Korean population. Rheumatol Int 2012: 32: 509-12.
16. Rizzo R, Rubini M, Govoni M et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006: 16: 615-23.
17. Kosoy R, Nassir R, Tian C et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009: 30: 69-78.
18. Coelho AV, Moura R, Addobbati C et al. A rapid screening of ancestry for genetic association studies in an admixed population from Pernambuco, Brazil. Genet Mol Res (in press).
19. Gobin SJ, Biesta P, de Steenwinkel JE, Datema G, van den Elsen PJ. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J Biol Chem 2002: 277: 39525-31.
20. Lefebvre S, Berrih-Aknin S, Adrian F et al. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem 2001: 276: 6133-9.
21. Ibrahim EC, Morange M, Dausset J, Carosella ED, Paul P. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chaperones 2000: 5: 207-18.
22. Gobin SJ, Keijsers V, Zutphen M, van den Elsen PJ. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol 1998: 161: 2276-83.
23. Hviid TV, Sorensen S, Morling N. Polymorphism in the regulatory region located more than 1.1 kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene. Hum Immunol 1999: 60: 1237-44.
24. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006: 21: 1743-8.
25. Moreau P, Mouillot G, Rousseau P, Marcou C, Dausset J, Carosella ED. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci U S A 2003: 100: 1191-6.
26. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14bp deletion-insertion polymorphism in the 3'UT region of the HLA-G gene influences HLA-G. Hum Immunol 2003: 64: 1005-10.
27. Suryanarayana V, Rao L, Kanakavalli M et al. Association between novel HLA-G genotypes and risk of current miscarriages: a case-control study in a South Indian population. Reprod Sci 2008: 15: 817-24.
28. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Review. Cell Mol Life Sci 2010: 68: 369-95.
29. Solier C, Mallet V, Lenfant F, Bertrand A, Huchenq A, Le Bouteiller P. HLA-G unique promoter region: functional implications. Review. Immunogenetics 2001: 53: 617-25.
30. Castelli EC, Mendes-Junior CT, Deghaide NH et al. The genetic structure of 3' untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010: 11: 134-41.
31. Rizzo R, Farina I, Bortolotti D et al. HLA-G may predict the disease course in patients with early rheumatoid arthritis. Hum Immunol 2013: 74: 425-32.
32. Lee HM, Sugino H, Aoki C et al. Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis. Arthritis Res Ther 2011: 13: R89.
33. Veit TD, de Lima CP, Cavalheiro LC et al. HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil. Tissue Antigens 2014: 83: 260-6.
34. Baricordi OR, Govoni M, Rizzo R, Trotta F. In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment. Ann Rheum Dis 2007: 66: 1125-6.
35. Stamp LK, O'Donnell JL, Chapman PT et al. Lack of association between HLA-G 14bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis. Ann Rheum Dis 2009: 68: 154-5.
36. Svendsen SG, Hantash BM, Zhao L et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3'-untranslated region. Hum Immunol 2013: 74: 818-27.
37. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
38. Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis clessification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010: 69: 1580-8.
39. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Review. Clin Exp Rheumatol 2005: 23: S100-8.
40. Fries JF, Spitz P, Kraines RG, Holmon HR. Measurement of patients outcome in arthritis. Arthritis Rheum 1980: 23: 137-45.
41. Gomez-Casado E, Martinez-Lasot J, Castro MJ et al. Detection of HLA-E and -G DNA alleles for population and disease studies. Cell Mol Life Sci 1999: 56: 356-62.
42. Excoffier L, Laval G, Schneider S. Arlequin ver 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 2005: 1: 47-50.